Panacea Life Sciences
(OTC) PLSH
Panacea Life Sciences Financials at a Glance
Market Cap
$911,800
Revenue (TTM)
$910.52K
Net Income (TTM)
$416.68K
EPS (TTM)
$0.13
P/E Ratio
0.34
Dividend
$0.00
Beta (Volatility)
-5.83 (Low)
Dividend
$0.00
Beta (Volatility)
-5.83 (Low)
Price
$0.04
Volume
15
Open
$0.04
Price
$0.04
Volume
15
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.03 - $0.20
Dividend
$0.00
Beta (Volatility)
-5.83 (Low)
Price
$0.04
Volume
15
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.03 - $0.20
PLSH News
PLSH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Panacea Life Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
25
CEO
Leslie Buttorff
Website
www.panacealife.comHeadquarters
Greenwood Village, CO 80121, US
PLSH Financials
Key Financial Metrics (TTM)
Gross Margin
-1%
Operating Margin
-2%
Net Income Margin
-46%
Return on Equity
0%
Return on Capital
-33%
Return on Assets
-7%
Earnings Yield
2.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$911.80K
Shares Outstanding
20.26M
Volume
15
Short Interest
0.00%
Avg. Volume
9.46K
Financials (TTM)
Gross Profit
$1.22M
Operating Income
$1.75M
EBITDA
$18.19K
Operating Cash Flow
$617.48K
Capital Expenditure
$0.00
Free Cash Flow
$617.48K
Cash & ST Invst.
$41.43K
Total Debt
$214.75K
Panacea Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$49.74K
-94.6%
Gross Profit
$1.73M
-335.8%
Gross Margin
-34.75%
N/A
Market Cap
$911.80K
N/A
Market Cap/Employee
$22.80K
N/A
Employees
40
N/A
Net Income
$1.20M
-134.8%
EBITDA
$2.49M
-163.6%
Quarterly Fundamentals
Net Cash
$173.33K
+98.7%
Accounts Receivable
$0.00
-100.0%
Inventory
$3.28M
-10.3%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$214.75K
-98.0%
Return on Assets
-7.45%
N/A
Return on Invested Capital
-32.58%
N/A
Free Cash Flow
$2.04M
+12.2%
Operating Cash Flow
$2.04M
+14.8%